Company Name or Ticker Symbol
Search for other Categories
Online Disruptive Technologies, Inc.  (ODT)
Other Ticker:  
    Sector  Technology    Industry Software & Programming
   Industry Software & Programming
   Sector  Technology
Price: $26.0000 $-0.52 -1.961%
Day's High: $ 26.49 Week Perf: -4.2 %
Day's Low: $ 25.64 30 Day Perf: 7.13 %
Volume (M): 52 52 Wk High: $ 32.00
Volume (M$): $ 1,362 52 Wk Avg: $ 23.41
Open: 26.33 52 Wk Low: 15.15
  ODT Charts & Quotes
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 633
 Shares Outstanding (Millions) 24
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) 0
Online Disruptive Technologies, Inc.

We were incorporated in the State of Nevada on November 16, 2009 under the name “Online Disruptive Technologies, Inc.” with authorized capital of 500,000,000 shares of common stock with a par value of $0.001 per share and 20,000,000 shares of preferred stock with a par value of $0.001 per share. On March 24, 2010, we entered into a share purchase agreement with Benjamin Cherniak, whereby we acquired all of the issued and outstanding shares of RelationshipScoreboard.com Entertainment, Inc. (“RSE”) in consideration for the issuance of 16,000,000 of our common shares. RSE was incorporated in the State of Nevada on November 16, 2009. There were no related party interests in the acquisition of RSE.

The Savicell™ platform is a blood test designed for the early detection of disease. It is a broad platform with applications for cancer, autoimmune diseases, and infectious diseases. While our focus initially is on early diagnosis of disease, we believe our technology may have additional applications in drug response monitoring for therapies that impact immune response. Immunotherapy, both for treating cancer and autoimmune diseases, is an example where metabolic shift profiles could indicate response to drug treatment.

Initially, Savicell is focused on the multibillion-dollar cancer diagnosis market. Savicell deploys Well-Shield™ technology, a Liquid ImmunoBiopsy™ diagnostic platform. In contrast to existing technologies that evaluate secretions of cancer cells, Well-Shield’s ImmunoBiopsy platform receives data directly from the immune system. Importantly, Well-Shield is different in that it is a functional test measuring the metabolic activation profile of the immune system as an indicator of disease status. As an immune system test, it is inherently suited for early detection.

The technology has now received intellectual property protection with a patent approved in the United States, China, Japan and Europe. Furthermore, the patent process is ongoing in several other countries.

Disease intrusion and cell malformation, including cancer, are first detected by the immune system, which energizes to rid the body of the malignancy. The initial immune response to disease is intricate, deploying different metabolic pathways and subtypes of cells. The Well-ShieldTM technology is designed to detect and interpret these differential metabolic responses.

  Company Estimates  
  Revenue Outlook
Online Disruptive Technologies does not provide revenue guidance.

Earnings Outlook
Online Disruptive Technologies, Inc. does not provide earnings estimates.


Sapiens International Corp N V

A $2.56 million tax benefit, helped Sapiens International Corp N V to post $0.01 eps in the forth quarter

A $2.56 million tax benefit, helped Sapiens International Corp N V to post $0.01 eps in the forth quarter

announced first quarter operating income of $5.763 millions

In the first quarter eps of $0.54 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Revenues fell sharply by -92.52 % to $13.89 millions from $185.64 millions in the same quarter a year ago and sequentially from $0.00 millions.

ODT's Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 3.33
ODT's Financial Strength Current
Quick Ratio 20.13
Working Capital Ratio 20.5
Leverage Ratio (MRQ) 0.05
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -
Per Share Current
Earnings (TTM) -0.7 $
Revenues (TTM) 0 $
Cash Flow (TTM) -0 $
Cash 8.02 $
Book Value 7.8 $
Dividend (TTM) 0 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
ODT's Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -
ODT's Profitability Ratio Current
Gross Margin -
Operating Margin -
Net Margin -
Net Cash Flow Margin -
Effective Tax Rate (TTM) -
Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Payout Ratio (TTM) -
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness

You need to upgrade your Flash Player

You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

HEB's Profile

Stock Price

HEB's Financials

Business Description


Charts & Quotes

HEB's News


HEB's Competitors

Customers & Markets

Economic Indicators

HEB's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength



Management Effectivness


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071